Purple Biotech (PPBT) Non Operating Investment Income (2014 - 2025)
Purple Biotech's (PPBT) quarterly Non Operating Investment Income came in at $61000.0 in Q4 2025, up 180.26% year-on-year from $21765.3 in Q4 2024, and up 180.26% on a QoQ basis from -$76000.0 in Q4 2024.
Purple Biotech (PPBT) Non Operating Investment Income (2014 - 2025) Analysis & Trends
Purple Biotech (PPBT) has 9 years of Non Operating Investment Income data on file, last reported at $61000.0 in Q4 2025.
- On a quarterly basis, Non Operating Investment Income rose 180.26% year-over-year to $61000.0 in Q4 2025; TTM through Dec 2025 was -$2.8 million, a 55.9% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, down 54.38% from the prior year.
- Non Operating Investment Income for Q4 2025 stood at $61000.0, up from -$76000.0 in the prior quarter.
- Over the last five years, Non Operating Investment Income for PPBT reached as high as $61000.0 in Q4 2025 and fell as low as -$3.5 million in Q4 2023.
- Historically, Non Operating Investment Income has averaged -$1.3 million across 3 years, with a median of -$946000.0 in 2024.
- Across the five-year window, Non Operating Investment Income soared 97.83% in 2024 and soared 180.26% in 2025, its largest moves.
- Year by year, Non Operating Investment Income stood at -$3.5 million in 2023, then surged by 97.83% to -$76000.0 in 2024, then surged by 180.26% to $61000.0 in 2025.
- Per Business Quant data, the three most recent Non Operating Investment Income figures were $61000.0 in Q4 2025, -$76000.0 in Q4 2024, and -$1.8 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Purple Biotech | 1.35 Bn | 1.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 61,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Dec 31, 2024 | -76,000.00 |
| Dec 31, 2024 | -76,000.00 |
| Sep 30, 2024 | -1.85 Mn |
| Sep 30, 2024 | -1.85 Mn |
| Jun 30, 2024 | -946,000.00 |
| Jun 30, 2024 | -946,000.00 |
| Dec 31, 2023 | -3.50 Mn |
| Dec 31, 2023 | -3.50 Mn |
| Dec 31, 2019 | -517,000.00 |
| Dec 31, 2019 | -517,000.00 |
| Dec 31, 2018 | -3.20 Mn |
| Dec 31, 2018 | -3.20 Mn |
| Dec 31, 2017 | 1.05 Mn |
| Dec 31, 2017 | 1.05 Mn |
| Dec 31, 2016 | 5.02 Mn |
| Dec 31, 2016 | 5.02 Mn |
| Dec 31, 2015 | -94,000.00 |
| Dec 31, 2015 | -94,000.00 |